alexa Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?
Cardiology

Cardiology

Cardiovascular Therapy: Open Access

Author(s): GCOCCO

Abstract Share this page

Given the prevalence, high morbidity, mortality and impaired quality of life, ischemic heart disease (IHD) is a major medical challenge. The use of myocardial revascularization techniques and of antianginal and cardioprotective drugs had an outstanding positive therapeutic impact. However, under anatomic circumstances in some patients a complete revascularization may be impossible, for example, after previous interventions or in the presence of peripheral pathology. In some patients conventional antianginal drugs, such as β-blockers, calcium-channel blockers, nicorandil (a nitrate and K+- and ATP-channel agonist), molsidomine and ivabradine either exert reduce symptoms to an insufficient extent or the therapy induces limiting side effects. Last, up to 10% of all patients with angina pectoris (mostly women) have symptoms and cardiac ischemia in the absence of significant coronary artery disease, supposedly because of microcoronary dysfunction.

  • To read the full article Visit
  • Open Access
This article was published in Expert Opinion on Pharmacotherapy and referenced in Cardiovascular Therapy: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords